John Cochran - Jun 21, 2023 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 12:24 PM
Previous filing
Jun 24, 2022
Next filing
Jun 21, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AQST Common Stock 99.5K Jun 21, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Stock Option (Right to Purchase) Award $0 +25K $0.00 25K Jun 21, 2023 Common Stock 25K $2.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.